Hongxiang Wang

4.2k citations
86 papers · 2.8k indexed · 2 hit papers · h-index 24
Topics
Extracellular vesicles in disease (13 papers)MicroRNA in disease regulation (8 papers)Chronic Myeloid Leukemia Treatments (8 papers)

In The Last Decade

Hongxiang Wang

84 papers receiving 2.8k citations

Hit Papers

ImmuCellAI: A Unique Method for Comprehensive T‐Cell Subs...202020262022202420202025200400600

Peers

Hongxiang Wang
Comparison fields: 5 of 127
  • Molecular Biology 1.1k
  • Oncology 613
  • Cancer Research 592
  • Pulmonary and Respiratory Medicine 379
  • Organic Chemistry 378
Replace Ting Niu with:
Ting Niu China
Yu Chang China
Jinxiang Han China
Ciprian Tomuleasa Romania
Shigeki Sato Japan
Shuang Qin China
Lizhi Zhang United States
Christian Urban Austria
D L Trump United States
Frank Gieseler Germany
Hongxiang Wang relative to Ting Niu China Ting Niu's profile →
Citations per field
00.5×2.9×
Ting Niu · 1×
Citations per year

Countries citing papers authored by Hongxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Hongxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongxiang Wang more than expected).

Fields of papers citing papers by Hongxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongxiang Wang. The network helps show where Hongxiang Wang may publish in the future.

Co-authorship network of co-authors of Hongxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Hongxiang Wang. A scholar is included among the top collaborators of Hongxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongxiang Wang. Hongxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 1
4 2
5 3
6 4
7 0
8 10
9 8
10 2
11 6
12 30
13 10
14 21
15 32
16 55
17 137
18 14
19 81
20 39

About Hongxiang Wang

Hongxiang Wang is a scholar working on Hematology, Genetics and Cancer Research, having authored 86 papers that have together received 2.8k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (13 papers), MicroRNA in disease regulation (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Cancer Research (592 citations), Genetics (333 citations) and Oncology (613 citations). Hongxiang Wang has collaborated with scholars based in China, France and United Kingdom. Frequent co-authors include Qian Lei, An‐Yuan Guo, Zhichao Chen, Qiubai Li, Qiong Zhang, Gui‐Yan Xie, Mei Luo, Ya‐Ru Miao, Xiaobing Wan and Ji‐Jun Chen. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026